rGLP-1 protein: all 32 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy SubjectsTerminatedNCT02802514Phase 4Results posted
- An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus SubjectsTerminatedNCT02793154Phase 4Results posted
- Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus SubjectsTerminatedNCT02750930Phase 4Results posted
- A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy SubjectsCompletedNCT02496221Phase 4Results posted
- Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusCompletedNCT02465515Phase 4Results posted
- Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes MellitusCompletedNCT02229227Phase 3Results posted
- A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)CompletedNCT01733758Phase 3Results posted
- Albiglutide Glucose Clamp Study in Subjects With Type 2 DiabetesCompletedNCT01475734Phase 2Results posted
- Pharmacokinetics/Pharmacodynamics of AlbiglutideCompletedNCT01357889Phase 2Results posted
- A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart FailureCompletedNCT01357850Phase 2Results posted
- A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.CompletedNCT01128894Phase 3Results posted
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.CompletedNCT01098539Phase 3Results posted
- Dose Ranging Study of Albiglutide in Japanese SubjectsCompletedNCT01098461Phase 2Results posted
- A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin GlargineCompletedNCT00976391Phase 3Results posted
- Safety and Efficacy of Albiglutide in Type 2 DiabetesCompletedNCT00849056Phase 3Results posted
- Safety and Efficacy Study of Albiglutide in Type 2 DiabetesCompletedNCT00849017Phase 3Results posted
- A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesCompletedNCT00839527Phase 3Results posted
- A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 DiabetesCompletedNCT00838916Phase 3Results posted
- Efficacy and Safety of Albiglutide in Treatment of Type 2 DiabetesCompletedNCT00838903Phase 3Results posted
- Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin OnlyCompletedNCT00518115Phase 2Results posted
- A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes MellitusWithdrawnNCT03015519Phase 3
- Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes MellitusWithdrawnNCT02229240Phase 3
- Albiglutide Thorough ECG Study in Healthy VolunteersCompletedNCT01406262Phase 1
- A Drug Interaction Study With Albiglutide and WarfarinCompletedNCT01147731Phase 1
- A Drug Interaction Study of Albiglutide and DigoxinCompletedNCT01147718Phase 1
- A Drug Interaction Study of Simvastatin and AlbiglutideCompletedNCT01147692Phase 1
- An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .CompletedNCT01077505Phase 1
- A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.CompletedNCT00938158Phase 1
- Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.CompletedNCT00537719Phase 1
- Clinical Assessment of GSK716155 for Type 2 Diabetes MellitusCompletedNCT00530309Phase 1
- Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy VolunteersCompletedNCT00394030Phase 1
- In-patient Study With GSK716155 In Patients With Type 2 Diabetes MellitusCompletedNCT00354536Phase 2